IDiyas

For the Inventor, By the Inventor

Blacksburg, VA, United States of America

Jaroslaw Kanski

USPTO Granted Patents = 30 


 

Average Co-Inventor Count = 6.3

ph-index = 8

Forward Citations = 164(Granted Patents)


Company Filing History:

goldMedal28 out of 56 
 
Kempharm, Inc.
 patents
silverMedal1 out of 1 
 
Kempharma, Inc.
 patent
bronzeMedal1 out of 1 
 
Kempham, Inc.
 patent

Years Active: 2013-2020

Loading Chart...
Loading Chart...
Loading Chart...
30 patents (USPTO):
1. 10870654 - Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same (2020-12-22),
2. 10849981 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-12-01),
3. 10758528 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof (2020-09-01),
4. 10654863 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-05-19),
5. 10577376 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof (2020-03-03),
6. 10544153 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof (2020-01-28),
7. 10463660 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof (2019-11-05),
8. 10441661 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof (2019-10-15),
9. 10358452 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2019-07-23),
10. 10351574 - Pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester and processes for making same (2019-07-16),
11. 10351573 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and uses thereof (2019-07-16),
12. 10258696 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof (2019-04-16),
13. 10144740 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxycodone, prodrugs, methods of making and use thereof (2018-12-04),
14. 10071091 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof (2018-09-11),
15. 10064956 - Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof (2018-09-04),

Title: Innovations and Contributions of Jaroslaw Kanski

Introduction: Jaroslaw Kanski is a prominent inventor based in Blacksburg, VA, known for his significant contributions to pharmaceutical sciences. With a remarkable portfolio that includes 30 patents, Kanski has focused on developing novel prodrugs and compositions that aim to improve pain management while minimizing side effects associated with traditional opioid therapies.

Latest Patents: Among his latest patents, Kanski has made strides in the formulation of pharmaceutically acceptable salts and polymorphic forms of hydrocodone benzoic acid enol ester. These innovations include processes for creating various polymorphs and the preparation of hydrocodone benzoic acid enol ester salts. Another significant patent involves the development of compositions that combine acetaminophen and benzoate-hydrocodone hydrochloride, aimed at treating patients experiencing moderate to severe pain while effectively addressing issues related to narcotic or opioid abuse and withdrawal.

Career Highlights: Throughout his career, Kanski has worked with notable companies such as Kempharm, Inc. and Kempharma, Inc. His innovative approach has led to a series of advancements in the pharmaceutical industry, focusing on creating safer and more effective treatments for patients suffering from pain.

Collaborations: Kanski has collaborated with several accomplished professionals in the field, including Travis C. Mickle and Sven Guenther. These partnerships have been instrumental in driving forward his research and development efforts, facilitating the production of groundbreaking pharmaceutical solutions.

Conclusion: Jaroslaw Kanski's dedication to innovation in the field of pharmaceuticals highlights the importance of ongoing research and development in improving patient care. His extensive patent portfolio and collaborations with industry experts underscore his commitment to enhancing analgesic therapies while addressing the growing concerns of opioid safety and efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…